Viewing Study NCT03694834


Ignite Creation Date: 2025-12-25 @ 2:22 AM
Ignite Modification Date: 2026-02-27 @ 5:17 AM
Study NCT ID: NCT03694834
Status: TERMINATED
Last Update Posted: 2023-11-28
First Post: 2018-10-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Window of Opportunity Pilot Study of Pembrolizumab in Obesity-driven Endometrial Cancer
Sponsor: UNC Lineberger Comprehensive Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Endometrial Cancer View
None Uterine Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Endometrial Cancer View
None Uterus View
None Endometrioid View